ABSTRACT

KEYWORDS

REFERENCES

1. ALAT. Declaración de las Sociedades Científicas Neumológicas iberolatino- americanas sobre los dispositivos electrónicos de liberación de nicotina. 2019.

2. Jenssen BP, Walley SC; SECTION ON TOBACCO CONTROL. E-Cigarettes and similar devices. Pediatrics 2019;143(2). pii: e20183652. doi: 10.1542/peds.2018-3652.

3. Statement from CDC Director Robert R. Redfield, M.D., and Acting FDA Commissioner Ned Sharpless, M.D., on federal and state collaboration to investigate respiratory illnesses reported after use of e-cigarette products. 2019.

4. HHS.gov. HHS Secretary Azar Statement on Illnesses Associated with E-Cigarettes. 2019.

5. Severe Pulmonary Disease Associated with Using E-Cigarette Products. 2019.

6. E-Cigarette products: Safety communication - Due to the incidents of severe respiratory disease associated with use of an E-Cigarette product. 2019. Disponible en: https://www.fda.gov/safety/medwatchsafety- alerts-human-medical-products/e-cigarette-productssafety- communication-due-incidents-severe-respiratory-diseaseassociated- use-e.

7. Shmerling RH. Can vaping damage your lungs? What we do (and don’t) know. 2019. Disponible en: https://www.health.harvard. edu/blog/can-vaping-damage-your-lungs-what-we-do-and-dontknow- 2019090417734.

8. Schier JG, Meiman JG, Layden J, Mikosz CA, VanFrank B, King BA, et al. Severe pulmonary disease associated with electroniccigarette– product use —interim guidance. MMWR Morb Mortal Wkly Rep [Internet]. 2019 [cited 2019 Sep 9];68(36). Available from: http://www.cdc.gov/mmwr/volumes/68/wr/mm6836e2. htm?s_cid=mm6836e2_w

9. Davidson K, Brancato A, Heetderks P, Mansour W, Matheis E, Nario M, et al. Outbreak of electronic-cigarette–associated acute lipoid pneumonia — North Carolina, July–August 2019. MMWR Morb Mortal Wkly Rep [Internet]. 2019 [cited 2019 Sep 9];68(36). Available from: http://www.cdc.gov/mmwr/volumes/68/wr/mm6836e1. htm?s_cid=mm6836e1_w

10. Disease Control C, Center for Chronic Disease Prevention N, Promotion H, on Smoking O. Department of Health U, Services H, for Disease Control C, Center for Chronic Disease Prevention N, Promotion H, on Smoking O. E-cigarette use among youth and young adults: a report of the surgeon general. 2016. Available from: https://www.cdc.gov/tobacco/data_statistics/sgr/e-cigarettes/ pdfs/2016_sgr_entire_report_508.pdf.

11. Chun LF, Moazed F, Calfee CS, Matthay MA, Gotts JE. Pulmonary toxicity of e-cigarettes. Am J Physiol Lung Cell Mol Physiol 2017;313(2):L193-L206. doi: 10.1152/ajplung.00071.2017.

12. Kaur G, Pinkston R, Mclemore B, Dorsey WC, Batra S. Immunological and toxicological risk assessment of e-cigarettes. Eur Respir Rev 2018;27(147):pii170119. doi: 10.1183/16000617.0119-2017.

13. Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde M, et al. Pulmonary illness related to E-Cigarette use in Illinois and Wisconsin —Preliminary report. N Engl J Med 2019. doi: 10.1056/ NEJMoa1911614.

14. Thirión-Romero I, Pérez-Padilla R, Zabert G, Barrientos-Gutiérrez I. Respiratory impact of electronic cigarettes and Low-Risk tobacco. Rev Invest Clin [Internet]. 2019 [cited 2019 Sep 3];71(1). Available from: http://www.clinicalandtranslationalinvestigation.com/frame_esp. php?id=199